Sep 26, 2023 / 04:25PM GMT
Charles Duncan -
Next presenting company. I'm Charles Duncan. I'm a Biotech Analyst with Cantor. And it's a pleasure to introduce Jazz Pharmaceuticals, who's going to present at the Cantor 2023 Global Healthcare Conference. Jazz Pharmaceuticals is a company I've known for a long time. But I only recently had an opportunity to take over coverage. And so it's an exciting time for this company that I've previously known as a neuro innovator, but it clearly has a very interesting oncology pipeline as well.
So it's a pleasure to introduce Bruce Cozadd the company's Chairman and CEO, Bruce. Nice to see you. Thanks for coming. Robert Iannone, the company's Global Head of R&D, Rob, nice to see you. And Kim Sablich, the company's EVP and GM. So sorry for the delay. I had to run upstairs and grab a tylenol, but with that, we'll have Bruce give us an overview on Jazz, and then I'll pepper him with a few questions. Bob?
Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO
Awesome. And Charles, thanks for the introduction. I'm glad to be here at
Jazz Pharmaceuticals PLC at Cantor Fitzgerald Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot